An evaluation of the effects of high‐dose fexofenadine on the central nervous system: a double‐blind, placebo‐controlled study in healthy volunteers
暂无分享,去创建一个
I Hindmarch | I. Hindmarch | Z. Shamsi | S. Kimber | Z Shamsi | S Kimber
[1] I. Hindmarch,et al. Comparison of five anxiolytic benzodiazepines on measures of psychomotor performance and sleep. , 1990, Neuropsychobiology.
[2] B. Jarvis,et al. Fexofenadine , 2000, Drugs.
[3] F. Gengo,et al. Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine. , 1987, Annals of allergy.
[4] I. Hindmarch. A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour. , 1975, Arzneimittel-Forschung.
[5] A. Nicholson,et al. Studies on the central effects of the H1-antagonist, loratadine , 2004, European Journal of Clinical Pharmacology.
[6] E. Juniper,et al. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] Herbert M. Simpson,et al. DRUGS DETECTED IN FATALLY INJURED DRIVERS IN THE PROVINCE OF ONTARIO , 1981 .
[8] K. Simons,et al. Peripheral H1-blockade effect of fexofenadine. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[9] F. Simons. Non‐cardiac adverse effects of antihistamines (H1‐receptor antagonists) , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[10] E. Volkerts,et al. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness , 1992 .
[11] I Hindmarch,et al. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. , 1980, British journal of clinical pharmacology.
[12] I. Hindmarch,et al. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side‐effects , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[13] I. Hindmarch,et al. The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers , 2004, European Journal of Clinical Pharmacology.
[14] I. Hindmarch,et al. The Effects of Practice on Choice Reaction Time and Critical Flicker Fusion Threshold , 1997 .
[15] I Hindmarch. Psychomotor function and psychoactive drugs. , 1980, British journal of clinical pharmacology.
[16] H. Roberts,et al. How many people think they have hay fever, and what they do about it. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.
[17] J. F. O'Hanlon,et al. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving , 2004, European Journal of Clinical Pharmacology.
[18] F E Simons,et al. Comparison of the central nervous system effects produce by six H1‐receptor antagonists , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[19] J. Bousquet,et al. The clinical safety of H1‐receptor antagonists: An EAACI position paper * , 1996, Allergy.
[20] J. Ortonne,et al. Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: A placebo-controlled, parallel-group, dose-ranging study , 1998 .
[21] F. Simons,et al. Central nervous system effects of H1-receptor antagonists in the elderly. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[22] D. B. Tower. Cerebral circulation revisited: An historical essay , 1991, Neurochemical Research.
[23] John R Bloomfield,et al. Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance , 2000, Annals of Internal Medicine.
[24] I. Hindmarch,et al. A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity , 1993 .
[25] A N Nicholson,et al. Antihistamines and aircrew: usefulness of fexofenadine. , 2000, Aviation, space, and environmental medicine.
[26] A. Parrott,et al. Critical Flicker Fusion Thresholds and Their Relationship to Other Measures of Alertness , 1982 .
[27] P. Howarth,et al. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. , 1999, The Journal of allergy and clinical immunology.
[28] A. Gaillard,et al. The influence of antihistamines on human performance , 2004, European Journal of Clinical Pharmacology.
[29] G S Watson,et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. , 2000, Annals of internal medicine.
[30] I. Hindmarch,et al. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. , 1999, British journal of clinical pharmacology.
[31] J. O'hanlon,et al. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. , 1998, The Journal of allergy and clinical immunology.
[32] A. Harris,et al. Loratadine: a non‐sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[33] G. Starmer. Antihistamines and highway safety. , 1985, Accident; analysis and prevention.